US Patent 9352051 Kits containing DLL3 antibody drug conjugates
Patent 9352051 was granted and assigned to Stemcentrx, Inc. on May, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9352051 Kits containing DLL3 antibody drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.